HRT risks and benefits

Key Facts

HRT is the most effective treatment for moderate to severe menopausal symptoms. When started before age 60 or within 10 years of your last period, the benefits typically outweigh the risks. The risks vary significantly by type (estrogen-only is much safer than combined therapy), route (transdermal is safer than oral), dose, and how long you take it. The decision isn't whether HRT is "safe" or "dangerous" in absolute terms, but whether the specific benefits matter to you more than the specific risks for your situation.

Recent research, particularly updated guidelines from NICE in 2024, confirms that HRT has no impact on overall life expectancy. You're not trading years of life for symptom relief. The calculation is more nuanced: do the benefits align with your priorities, and are the risks acceptable given your health profile?

Understanding the Evidence: The WHI Study and Beyond

What the WHI Study Actually Showed

In 2002, the Women's Health Initiative (WHI) published findings that shook the field: a major trial of HRT was stopped early because of increased risks of heart disease, stroke, blood clots, and breast cancer. The headlines were alarming. Millions of women stopped HRT. Doctors became cautious. This one study dominated menopause care for over 20 years.

But the study had significant limitations that weren't widely publicized at the time.

The Critical Context

Study population: The WHI included women with an average age of 63, weighted toward women already past menopause and older. Younger women transitioning through menopause were underrepresented. This matters because the risks are higher in older women and the benefits are stronger in younger women.

One medication only: The study used only one type of HRT: oral conjugated equine estrogen (CEE, 0.625 mg) combined with oral medroxyprogesterone acetate (MPA, 2.5 mg) taken every day continuously. The findings were then applied to all HRT types: patches, gels, different estrogens, different progestins, different doses, and different schedules. This was a logical leap that the data didn't fully support.

Benefits were overlooked: The study also found benefits: fewer hip fractures (about one-third reduction) and fewer colorectal cancers. These findings were overshadowed by safety concerns and rarely mentioned in the headlines.

Reanalysis and Modern Evidence

Subsequent reanalysis of the WHI data and new studies showed a striking pattern: HRT in younger women or early postmenopausal women (under 60, or within 10 years of the last period) actually reduced cardiovascular disease and all-cause mortality. The increased cardiovascular risk appeared only in women who started HRT more than 10-20 years after menopause, when heart disease risk naturally rises with age.

In 2024, NICE updated its guidance, emphasizing that HRT remains the most effective treatment for menopausal symptoms and confirming that it does not increase overall life expectancy.

The evidence now supports a key principle: timing matters. Starting HRT early (in your 50s or early 60s) carries a favorable benefit-to-risk profile. Starting at 70 or 80 would be different.

The Benefits

Symptom Relief (Vasomotor Symptoms)

This is HRT's clearest win. Hot flashes and night sweats disrupt sleep, cause embarrassment, and drain energy. HRT relieves these symptoms in 80-90% of women. Other women see partial relief. A few see no improvement, though this is less common.

The relief comes quickly: many women notice improvement within 2-4 weeks, with full benefit by 3 months.

Why this matters: Untreated severe night sweats can fragment sleep by 20-30%, leading to chronic fatigue, cognitive problems, and mood disruption. Symptom relief translates directly to better sleep and better functioning.

Vaginal and Urinary Symptoms

Vaginal dryness, painful intercourse, urinary frequency, and incontinence improve significantly with HRT. For many women, this restoration of sexual comfort and urinary function is as important as hot flash relief.

Localized vaginal HRT (creams, tablets, or rings) can be used alone if these are your only symptoms, with minimal systemic absorption.

Bone Protection

Menopause brings rapid bone loss due to dropping estrogen levels. HRT slows or prevents this loss by 30-50%, reducing fracture risk. This is especially important for women with family history of osteoporosis or already low bone density.

The benefit is maintained while taking HRT but declines after stopping, so this is usually a shorter-term use benefit unless you're at very high fracture risk.

Cardiovascular Timing Hypothesis

This is where the timing of HRT becomes critical. New evidence shows that women who start HRT in their 50s, during the early postmenopausal years, may have a cardiovascular benefit: reduced coronary artery disease and lower all-cause mortality compared to untreated women.

The mechanism likely involves estrogen's effects on blood vessel function, cholesterol, and inflammation when your cardiovascular system is still relatively healthy. Once significant atherosclerosis has developed (typically 10+ years past menopause), HRT can't reverse the damage.

This doesn't mean HRT is a heart disease preventive for everyone, but for women in their 50s without existing heart disease, it may offer protection as a side benefit.

Quality of Life and Functional Impact

Beyond specific symptoms, HRT improves mood, energy, sleep, and cognitive clarity for many women. Depression and anxiety tied to menopause often improve. Mental fog (sometimes called "brain fog" or "chemo brain") clears.

For many women, the greatest benefit isn't any single symptom relief but the return to feeling like themselves.

The Risks

Breast Cancer: The Complex Picture

This is the risk most women worry about, and rightfully so, because it's the most common cancer in women. The good news: the risk varies dramatically by HRT type.

Estrogen-only HRT: Studies consistently show little to no increased risk of breast cancer with estrogen alone. Some studies show a slight decrease in breast cancer incidence and mortality. If you've had a hysterectomy and use estrogen-only HRT, your breast cancer risk is essentially unchanged.

Combined HRT (Estrogen + Progesterone): This carries a modest increased risk, particularly with long-term use. Large studies show:

• After 5 years of combined HRT: about 6 additional cases of breast cancer per 1,000 women
• The risk increases the longer you use it
• The risk decreases once you stop HRT
• Oral combined therapy carries higher risk than transdermal combined therapy
• Older synthetic progestins carry higher risk than micronized progesterone

Contextual risk: This sounds serious, but context matters. The increased breast cancer risk from HRT is smaller than the risk from obesity, regular alcohol use (more than one drink daily), or hormone-sensitive breast cancer itself (which carries much higher recurrence risk).

2025 Update: In September 2025, a panel of breast cancer experts recommended that some women with a history of ER-negative breast cancer could potentially take HRT after discussion with their oncologist to improve quality of life during menopause. This represents a shift toward more individualized decision-making.

Blood Clots (Venous Thromboembolism)

Oral HRT increases the risk of deep vein thrombosis (blood clots in the legs) and pulmonary embolism (clots in the lungs), with a relative increase of about 58% compared to non-users. This sounds large, but the absolute risk is still modest: roughly 3-5 additional cases per 10,000 women per year.

Route matters enormously: Transdermal HRT (patches, gels, sprays) carries no increased clotting risk. This is because transdermal hormones bypass the liver, avoiding the hepatic effects that trigger clotting factors.

Who's at higher risk: Women with personal or strong family history of blood clots, thrombophilia (clotting disorders), immobility (long bed rest, long flights), obesity, or recent surgery should avoid oral HRT but may safely use transdermal routes.

Stroke

HRT may increase stroke risk slightly, particularly with oral combined HRT and in older women (over 60). The relative increase is modest. Transdermal HRT shows less risk. The absolute number of extra strokes is small, but this is why HRT is not recommended as a heart disease preventive in women over 60 or more than 10 years past menopause.

Other Risks (Low Magnitude)

Gallbladder disease: Oral HRT slightly increases gallbladder problems, especially in the first year. Transdermal HRT shows no increased risk.

Migraine with aura: If you experience migraine with aura (visual disturbances before a headache), HRT can slightly increase stroke risk. Discuss this carefully with your neurologist and gynecologist.

Dementia: Earlier studies suggested HRT might increase dementia risk (from the WHI). Reanalysis and newer studies show no meaningful increased risk, and possible benefit if started in your 50s.

Vaginal bleeding: Some women on HRT experience unexpected bleeding or spotting, which requires evaluation to rule out other causes.

Who Benefits Most: The Window of Opportunity

The evidence is clearest for women in this group:

• Age 50-60, or within 10 years of last menstrual period
• Moderate to severe vasomotor symptoms or vaginal dryness
• No personal history of breast cancer, blood clots, or stroke
• Normal blood pressure
• Willing to take it for 5-10 years, then reassess

For these women, HRT offers strong symptom relief with favorable risks. Starting age matters. A 52-year-old has a very different benefit-risk calculation than a 72-year-old.

Who Should Be Cautious (Or Explore Further)

Personal History of Blood Clots or Stroke

Use transdermal HRT only. Avoid oral tablets. Even transdermal carries some risk, so this decision requires close discussion with your doctor.

Personal History of Breast Cancer

This used to be an absolute contraindication. Now it's more nuanced:

• ER-negative breast cancers: discussion about HRT is now reasonable
• ER-positive breast cancers: HRT increases recurrence risk and is generally avoided, though some women choose it despite this for quality of life
• In all cases, close involvement of your oncologist is essential

Family History of Breast Cancer

This doesn't automatically rule out HRT, but it warrants careful discussion. Your individual risk factors matter more than family history alone.

Over 60 Years Old

HRT can still be appropriate, but your doctor will likely recommend:

• Lower doses
• Transdermal routes (patches, gels, sprays)
• Shorter duration (2-5 years rather than 10)
• More frequent monitoring

The benefit-to-risk ratio is less favorable after 60, but it's not zero. Some women benefit greatly even at older ages.

Migraine with Aura

The combination of migraine with aura and HRT increases stroke risk beyond either alone. Discuss with a neurologist. Transdermal may be safer than oral, and low doses may be safer than high doses.

Uncontrolled High Blood Pressure

HRT can slightly raise blood pressure. Manage BP first, then reconsider HRT.

Making the Decision: Shared Decision-Making With Your Doctor

There is no objectively "right" choice about HRT. Two equally informed women with identical symptoms and health histories might reach opposite decisions, and both would be reasonable.

Here's how good shared decision-making works:

1. Understand Your Specific Symptoms

Don't think in generalities ("I have hot flashes"). Be specific:

• How often? How severe (1-10 scale)?
• When do they happen? (morning, night, random?)
• Impact on work, sleep, relationships?
• Any vaginal or urinary symptoms?
• Mood or cognitive changes?

Menovita can help you document this clearly.

2. Know Your Risk Profile

Work with your doctor to identify:

• Any personal history of blood clots, stroke, or heart attack
• Any personal history of breast cancer (and if so, hormone-receptor status)
• Family history of breast cancer, blood clots, or heart disease
• Current medications that might interact
• Current health conditions (liver disease, uncontrolled hypertension)
• Your age and years since last period

3. Discuss the Options

HRT isn't your only choice. Other options include:

• Non-hormonal treatments (SSRIs like sertraline, SNRIs like venlafaxine, gabapentin)
• Lifestyle changes (cooling techniques, exercise, sleep optimization, diet)
• Local vaginal treatments (creams, rings, tablets) if dryness is the main issue
• No treatment, just tracking and time (some women prefer to ride out menopause without medication)

4. If You Choose HRT, Plan the Details

• Which formulation? (patch, gel, tablet, etc.) Why that choice for you?
• What dose to start?
• How long will you try it before deciding if it's working?
• When will you follow up?
• What side effects warrant a call vs. what's normal adjustment?
• How long do you envision taking it?

5. Build in Reassessment

Plan to revisit the decision regularly: at 3 months (is it working?), at 6-12 months (are you stable?), and annually thereafter. This isn't a one-time decision locked in.

Key Principle: The "Window of Opportunity"

Modern evidence supports what researchers call the "timing hypothesis." HRT started early (in your 50s, within 10 years of menopause) in women without existing cardiovascular disease carries favorable risks. The same HRT started at age 70 in someone with established heart disease carries less favorable risks.

This doesn't mean HRT is only for the young. It means that age and time since menopause are crucial factors in the benefit-to-risk calculation. Your doctor should discuss this explicitly.

FAQs

Q: Does HRT really increase breast cancer risk?

A: Combined HRT does, modestly, particularly with long-term use (more than 5 years) and oral tablets. The increased risk is smaller than obesity or alcohol use. Estrogen-only HRT shows no increase. The risk decreases once you stop. It's real but not as catastrophic as headlines often suggest.

Q: If I take HRT, will I develop a blood clot?

A: No. Most women on HRT never develop a clot. Oral HRT increases your risk by about 58%, but the absolute risk is still low: about 3-5 extra cases per 10,000 women per year. Transdermal HRT carries no increased risk.

Q: What if I'm over 60? Can I take HRT?

A: Yes, but your doctor will likely recommend lower doses, transdermal routes, shorter duration, and more monitoring. The benefit-to-risk ratio is less favorable, so it's more individualized. It's not an automatic no, but the decision requires more careful discussion.

Q: Is bioidentical HRT safer than regular HRT?

A: Bioidentical hormones (like estradiol and micronized progesterone) are identical to your body's own hormones at the molecular level. They're not necessarily safer; the form (patch vs. tablet), dose, and type matter more. A bioidentical hormone in a risky form (like oral combined therapy) carries similar risks to synthetic hormones in that form. The buzzword "bioidentical" is often marketing, not a safety guarantee.

Q: Does HRT prevent heart disease?

A: It may help if you're in your 50s and start early, within 10 years of your last period. For women who start HRT older (over 60) or more than 10 years past menopause, HRT is not recommended as a preventive. Don't start HRT primarily for heart disease prevention; other measures (exercise, diet, managing cholesterol and blood pressure) matter more.

Q: What if I have a family history of breast cancer? Can I take HRT?

A: Family history alone doesn't rule it out, but it warrants discussion. Your individual risk factors matter more than family history alone. Some women with family history take HRT; others choose non-hormonal options. Both can be reasonable decisions.

Q: How do I know if HRT is working?

A: You should notice meaningful improvement in your symptoms within 3 months. For hot flashes, this typically means fewer hot flashes (not necessarily zero), occurring less frequently and less severely, and disrupting sleep less. For vaginal dryness, you'll notice improved comfort. For mood and energy, improvement is more subtle but noticeable. If after 3 months you have minimal improvement, talk to your doctor about adjusting dose or form.

Q: Will I gain weight on HRT?

A: HRT doesn't directly cause weight gain. Menopause, aging, and lifestyle changes all contribute. Some women find HRT helps with weight by improving energy and mood (making exercise easier). Others notice water retention or increased appetite early on (usually temporary). Focus on tracking to see what happens with your body specifically.

Q: What happens to my risk when I stop HRT?

A: The breast cancer risk begins declining immediately. Within a few years of stopping, your breast cancer risk returns to baseline. The same applies to blood clot risk with oral HRT. Symptom relief ends, and hot flashes often return (though not always to their original severity). Bone loss acceleration resumes after stopping.